Iconovo AB (ICO)
XSTO XSTO Primary Summary
Iconovo AB (ICO) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Iconovo AB ever had a stock split?
Iconovo AB Profile
| Pharmaceuticals Industry | Healthcare Sector | Mr. Anders Mansson CEO | XSTO Exchange | SE0010868943 ISIN |
| SE Country | 13 Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
Iconovo AB (publ), founded in 2013 and headquartered in Lund, Sweden, is a company that focuses on the development and licensing of inhalation devices. Its operations primarily cater to generic pharmaceutical companies, providing them with inhaler products that facilitate the delivery of powdered medications through the respiratory tract. Iconovo has established various agreements and collaborations, notable among them being with Immune System Regulation AB for the development of an inhaled COVID-19 vaccine using Iconovo's ICOone inhaler. Additionally, the company has partnerships for the development of a dry powder inhalation product with Respiratorius and a preventive oxytocin therapy with Monash University, aimed at providing protection against postpartum hemorrhage. This involvement in significant healthcare challenges underlines Iconovo's dedication to leveraging its technologies for global health improvement.
Products and Services
- ICOres - This is a versatile multi-dose dry powder inhaler designed to offer flexibility in dosing and a user-friendly mechanism for patients. The device is engineered to ensure precision and reliability in medication delivery.
- ICOcap - ICOcap is a capsule-based dry powder inhaler that is aimed at providing a simple yet effective method for administering powdered drugs. Its design allows for ease of use, catering to patients who prefer a capsule-based delivery system.
- ICOone - ICOone stands out as a single-dose disposable dry powder inhaler, distinguishing itself by its simplicity and disposability. This device is specifically tailored for treatments where a single-dose application is essential, enhancing adherence and convenience for one-time use scenarios.
- ICOpre - Iconovo's ICOpre is a pre-metered dry powder inhaler designed for precision. It offers a dose-ready inhalation device, minimizing pre-use preparation and ensuring that patients receive the correct dose with each use.
- ICOone Nasal - Extending the application of the ICOone technology, the ICOone Nasal is a single-dose disposable dry powder inhaler engineered for nasal administration. This variant taps into the benefits of nasal drug delivery, providing an alternative route that is particularly suitable for vaccines and treatments requiring mucosal absorption.
